SmartCatch
Company

Last deal

$2.63M
Local Amount - EUR 3.2M

Amount

Venture - Series Unknown

Stage

17.05.2021

Date

1

all rounds

$2.63M

Total amount

date founded

Financing round

General

About Company
SmartCatch develops liquid biopsy technology to fight cancer.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2016

founders

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's minimally invasive method extracts circulating tumor cells, providing researchers and clinicians with valuable data to improve cancer patient outcomes. SmartCatch's capture micro-devices, resembling micro-fishnets, can be used for early cancer diagnosis, personalized therapeutic follow-up, and pharmaceutical screening. The technology is based on precision medicine, which adapts medical treatment to the exact molecular profile of each patient, relying on the analysis of circulating biomarkers in patients' blood flow. SmartCatch was established in 2016 by multidisciplinary scientists and urologist surgeons from CNRS, IUCT-Oncopole, and Toulouse hospital, who patented the results of their research in 2015.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Rarecells

Rarecells

Rarecells, Inc. develops non-invasive early cancer detection tests based on the ISET® platform technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Paris, France

total rounds

2

total raised

$13M
Quanterix

Quanterix

Quanterix developed Simoa, a platform for single-molecule analysis in diagnostics, drug development, and research.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Life Science

Location

Billerica, MA, USA

total rounds

12

total raised

$533.3M
Kypha

Kypha

Kypha develops technology and clinical products to improve autoimmune disease treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

St. Louis, MO, USA

total rounds

15

total raised

$24.01M
Predicine

Predicine

Predicine is a molecular information company that develops genomic profiling tests and algorithms for cancer diagnostics and monitoring.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Hayward, CA, USA

Financials

Funding Rounds
1
1

Number of Funding Rounds

$2.63M

Money Raised

Their latest funding was raised on 17.05.2021. Their latest investor IRDI. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
17.05.2021
3
$2.63M
Local Amount - EUR 3.2M
Co-Investors
Investors
3
0

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
No
Venture - Series Unknown
No
Venture - Series Unknown
IRDI

IRDI

IRDI is a well-known venture capital firm founded in 1981, based in France, with a focus on investing in startups in the Southwest region.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services

Location

Toulouse, France

count Of Investments

38

count Of Exists

3
Jean-Michel Petit

Jean-Michel Petit

Jean-Michel Petit joined IRDI SORIDEC Gestion as Investment Director in 2003.

current job

IRDI
IRDI
M Capital Partners

M Capital Partners

M Capital Partners: Leading French Private Equity firm managing €500m in assets.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Toulouse, France

count Of Investments

99

count Of Exists

10
Kurma Partners

Kurma Partners

Kurma Partners specializes in financing healthcare and biotechnology innovation.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Health Care, Financial Services

Location

Paris, France

count Of Investments

89

count Of Exists

6
Alain Horvais

Alain Horvais

PhD in Molecular Biology from the University of Angers and an MS in Finance and Innovation management from Masternova – AgroPariTech. After his PhD, Alain started his own company, D-Genos in 1995, dedicated to the development of molecular (PCR based) assays for food and vegetable applications. He joined Bio-Rad France in 2001, as R&D Manager for the development of a range of IVD PCR assays. After the launch of the first products in 2011, he joined Astra Zeneca UK, as Diagnostic Team Director. Alain joined Kurma Partners in January 2015 as Partner for the Kurma Diagnostics fund. He is also a board member of APD (France) and Feetme (France).

current job

Kurma Partners
Kurma Partners

People

Founders
1
Aline Cerf
Aline Cerf

Aline Cerf

Aline Cerf is a CEO and co-founder at SmartCatch. She attended the National Institute of Applied Sciences of Toulouse.

current job

SmartCatch
SmartCatch

organization founded

1

Aline Cerf

Employee Profiles
1
Aline Cerf

Aline Cerf

Chief Executive Officer and Co-Founder

Activity

Recent News
0